Enova International: David Fisher sells 23,157 shares

Q: How many ENVA shares did David Fisher sell, and at what prices?

David Fisher sold 13,200 ENVA shares on October 27, 2026, at a weighted-average $171.7872 per share, and 9,957 shares on October 28, 2026, at $178.1570 per share; the reported total was 23,157 shares.

Q: Were David Fisher’s ENVA stock sales made under a trading plan?

Both sales were made pursuant to a Rule 10b5-1 trading plan adopted on January 30, 2026. The transactions followed option exercises on October 27 and October 28, with an exercise price of $20.73 per share.

Q: What were the trade price ranges for David Fisher’s ENVA sales?

For the October 27 sale, multiple trades ranged from $171.14 to $172.78 per share; the reported weighted average was $171.7872. For the October 28 sale, trades ranged from $172.29 to $180.32 per share, and the weighted average was $178.1570.

The weighted-average sale prices reflected multiple trades, with reported trade ranges of $171.14–$172.78 and $172.29–$180.32 per share.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Enova International, Inc. Executive Chairman David Fisher exercised options for 13,200 shares on October 27, 2026, and 9,957 shares on October 28, 2026, at an exercise price of $20.73 per share. He sold the same share counts at weighted-average prices of $171.7872 and $178.1570 per share, respectively. Both sales were made under a Rule 10b5-1 trading plan adopted on January 30, 2026.

Insider Trade Summary 10b5-1

Exercise and sale activity reported; no spread calculated

Exercise and Sale 6 txns

Insider Fisher David

Role Executive Chairman

Sold 23,157 shs ($4.04M)

Approx. gross sale proceeds $4.04M

Approx. exercise cost $480K

Type	Security	Shares	Price	Value
Exercise	Non-Qualified Stock Option (right to buy) with limited SAR ^{F4, F5, F6}	9,957	$0.00	$0.00
Exercise	Common stock, par value $0.00001 per share	9,957	$20.73	$206K
Sale	Common stock, par value $0.00001 per share ^{F1, F3}	9,957	$178.157	$1.77M
Exercise	Non-Qualified Stock Option (right to buy) with limited SAR ^{F4, F5, F6}	13,200	$0.00	$0.00
Exercise	Common stock, par value $0.00001 per share	13,200	$20.73	$274K
Sale	Common stock, par value $0.00001 per share ^{F1, F2}	13,200	$171.7872	$2.27M

Holdings After Transaction: Non-Qualified Stock Option (right to buy) with limited SAR — 122,206 contracts (Direct); Common stock, par value $0.00001 per share — 306,444 shares (Direct)

Footnotes (6)

F1. The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan adopted on January 30, 2026.
F2. This transaction was executed in multiple trades at prices ranging from $171.14 to $172.78. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.
F3. This transaction was executed in multiple trades at prices ranging from $172.29 to $180.32. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.
F4. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.
F5. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.
F6. The options vested in substantially equal one-third increments on each of the following dates: February 11, 2021, February 11, 2022, and February 11, 2023.

Key Figures

Shares exercised: 13,200 shares Shares exercised: 9,957 shares Option exercise price: $20.73 per share +4 more

7 metrics

Shares exercised 13,200 shares October 27, 2026

Shares exercised 9,957 shares October 28, 2026

Option exercise price $20.73 per share Options exercised October 27 and 28, 2026

Shares sold 13,200 shares October 27, 2026

Weighted-average sale price $171.7872 per share October 27, 2026

Shares sold 9,957 shares October 28, 2026

Weighted-average sale price $178.1570 per share October 28, 2026

Key Terms

Rule 10b5-1 trading plan, Non-Qualified Stock Option, limited stock appreciation right ("SAR"), weighted average sale price

4 terms

Rule 10b5-1 trading plan financial

"pursuant to the Reporting Person’s Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Non-Qualified Stock Option financial

"Non-Qualified Stock Option (right to buy) with limited SAR"

A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.

limited stock appreciation right ("SAR") financial

"The limited stock appreciation right ("SAR") and employee stock option"

weighted average sale price financial

"reflects the weighted average sale price"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ENVA shares did David Fisher sell, and at what prices?

David Fisher sold 13,200 ENVA shares on October 27, 2026, at a weighted-average $171.7872 per share, and 9,957 shares on October 28, 2026, at $178.1570 per share; the reported total was 23,157 shares.

Were David Fisher’s ENVA stock sales made under a trading plan?

Both sales were made pursuant to a Rule 10b5-1 trading plan adopted on January 30, 2026. The transactions followed option exercises on October 27 and October 28, with an exercise price of $20.73 per share.

What were the trade price ranges for David Fisher’s ENVA sales?

For the October 27 sale, multiple trades ranged from $171.14 to $172.78 per share; the reported weighted average was $171.7872. For the October 28 sale, trades ranged from $172.29 to $180.32 per share, and the weighted average was $178.1570.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 10/29/2026 - 06:00 PM EDT Accepted by SEC EDGAR 10/29/2026 - 06:00 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fisher David

(Last)

(First)

(Middle)

C/O ENOVA INTERNATIONAL, INC.

175 W. JACKSON BOULEVARD, SUITE 600

(Street)

CHICAGO

ILLINOIS

60604

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Enova International, Inc. [ ENVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Executive Chairman

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common stock, par value $0.00001 per share	10/27/2026		M		13,200	A	$20.73	319,644	D
Common stock, par value $0.00001 per share	10/27/2026		S⁽¹⁾		13,200	D	$171.7872⁽²⁾	306,444	D
Common stock, par value $0.00001 per share	10/28/2026		M		9,957	A	$20.73	316,401	D
Common stock, par value $0.00001 per share	10/28/2026		S⁽¹⁾		9,957	D	$178.157⁽³⁾	306,444	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Non-Qualified Stock Option (right to buy) with limited SAR⁽⁴⁾⁽⁵⁾	$20.73	10/27/2026		M			13,200	⁽⁶⁾	02/11/2027	Common stock; par value $0.00001 per share	13,200	$0	132,163	D
Non-Qualified Stock Option (right to buy) with limited SAR⁽⁴⁾⁽⁵⁾	$20.73	10/28/2026		M			9,957	⁽⁶⁾	02/11/2027	Common stock; par value $0.00001 per share	9,957	$0	122,206	D

Explanation of Responses:

1. The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan adopted on January 30, 2026.

2. This transaction was executed in multiple trades at prices ranging from $171.14 to $172.78. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.

3. This transaction was executed in multiple trades at prices ranging from $172.29 to $180.32. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.

4. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

5. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

6. The options vested in substantially equal one-third increments on each of the following dates: February 11, 2021, February 11, 2022, and February 11, 2023.

	/s/ Sean Rahilly, as attorney in fact	10/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR